NCT06663462Completed
EzPAP Therapy Versus Non-invasive Ventilation Therapy
EzPAP Therapy Versus Non-invasive Ventilation for Hypercapnic Chronic Obstructive Pulmonary Disease Exacerbataion: a Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 29 Oct 2024
Brief summary (registry, in English)
This study compared EzPAP and noninvasive treatments of hypercapnic COPD attacks.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 19 (actual)
- First submitted
- 19 Oct 2024
- Start date
- 15 Dec 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Kırklareli University
- Diseases
- COPD
- NCT number
- NCT06663462
What you commit to
- Study type: Observational
- Participants enrolled: 19
- From 15 Dec 2022 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cardiac failure Dead
Who the study is looking for
- Clinical diagnosis of Chronic obstructive pulmonary disease Dyspnea
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oya Guven, MD Coordinator of this site? Confirm its status | Kırklareli | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.